(Q39106632)

9 September 2017

title

Cathepsin L silencing enhances arsenic trioxide mediated in vitro cytotoxicity and apoptosis in glioblastoma U87MG spheroids (English)

1 reference

9 September 2017

0 references

0 references

1 reference

3

1 reference

9 September 2017

6

Rolf Bjerkvig

1 reference

9 September 2017

Monika Primon

1

1 reference

9 September 2017

Peter C Huszthy

2

1 reference

9 September 2017

Krishna M Talasila

4

1 reference

9 September 2017

Ana Torkar

5

1 reference

9 September 2017

Tamara Lah Turnšek

7

1 reference

9 September 2017

language of work or name

English

0 references

publication date

19 August 2013

1 reference

Experimental Cell Research

9 September 2017

published in

1 reference

9 September 2017

volume

319

1 reference

9 September 2017

issue

17

1 reference

9 September 2017

page(s)

2637-2648

1 reference

Glioblastoma--a moving target.

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Glioblastoma therapy: going beyond Hercules Columns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Protease signalling: the cutting edge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Antiprotease therapy in cancer: hot or not?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Cysteine cathepsins: multifunctional enzymes in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Distinct roles for cysteine cathepsin genes in multistage tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Cathepsin L in glioma progression: comparison with cathepsin B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Molecular mechanisms of glioma invasiveness: the role of proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Inhibition of cathepsin L lowers the apoptotic threshold of glioblastoma cells by up-regulating p53 and transcription of caspases 3 and 7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Arsenic trioxide - An old drug rediscovered

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Differential role of cathepsins B and L in autophagy-associated cell death induced by arsenic trioxide in U87 human glioblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Cathepsin L, target in cancer treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

A review of three-dimensional in vitro tissue models for drug discovery and transport studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Spontaneous Malignant Transformation of Human Mesenchymal Stem Cells Reflects Cross-Contamination: Putting the Research Field on Track - Letter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Activity-based probes that target diverse cysteine protease families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

An efficient, inexpensive, and shelf-stable diazotransfer reagent: imidazole-1-sulfonyl azide hydrochloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Synthesis of C-carbamoyl-1,2,3-triazoles by microwave-induced 1,3-dipolar cycloaddition of organic azides to acetylenic amides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Structure-based development of specific inhibitors for individual cathepsins and their medical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Secretome signature of invasive glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Secreted cathepsin L generates endostatin from collagen XVIII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

TNF-α contributes to caspase-3 independent apoptosis in neuroblastoma cells: role of NFAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Targeting proteases: successes, failures and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

RNA Interference and Cancer Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Multicellular resistance: a paradigm for clinical resistance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Quantitative spatiotemporal analysis of antibody fragment diffusion and endocytic consumption in tumor spheroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Penetration and binding of vinblastine and 5-fluorouracil in cellular spheroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Arsenic trioxide induces human pulmonary fibroblast cell death via the regulation of Bcl-2 family and caspase-8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Arsenic trioxide-induced apoptosis in TM4 Sertoli cells: the potential involvement of p21 expression and p53 phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

You say lipofuscin, we say ceroid: defining autofluorescent storage material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.011

10.1016/J.YEXCR.2013.08.011

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference